Has Chimerix (CMRX) Outpaced Other Medical Stocks This Year? 2020/01/03 16:30:08 Zacks Investment Research
Is (CMRX) Outperforming Other Medical Stocks This Year?
Chimerix Inc (NASDAQ:CMRX) Director Buys $54,600.00 in Stock 2019/11/15 18:37:00 Modern Readers
Chimerix Inc (NASDAQ:CMRX) Director Fred A. Middleton acquired 30,000 shares of the stock in a transaction on Wednesday, November 13th. The shares were acquired at an average price of $1.82 per share, with a total value of $54,600.00. Following the transaction, the director now directly owns 117,523 shares of the company’s stock, valued at $213,891.86. […]
Chimerix (NASDAQ:CMRX) Releases Earnings Results, Beats Estimates By $0.07 EPS 2019/11/08 16:04:19 Modern Readers
Chimerix (NASDAQ:CMRX) issued its earnings results on Tuesday. The biopharmaceutical company reported ($0.15) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.22) by $0.07, Fidelity Earnings reports. Chimerix had a negative net margin of 1,162.96% and a negative return on equity of 35.69%. The firm had revenue of $1.96 million during […]
Robert J. Meyer Purchases 10,000 Shares of Chimerix Inc (NASDAQ:CMRX) Stock 2019/11/08 14:50:50 Modern Readers
Chimerix Inc (NASDAQ:CMRX) Director Robert J. Meyer purchased 10,000 shares of the stock in a transaction dated Wednesday, November 6th. The shares were purchased at an average price of $1.58 per share, for a total transaction of $15,800.00. Following the completion of the transaction, the director now owns 10,000 shares in the company, valued at […]
The Daily Biotech Pulse: Akebia Sues CMS, Roche Raises Guidance Yet Again, Titan Medical Entangled In Credit Crunch 2019/10/16 11:06:15 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 15) Celgene Corporation (NASDAQ: CELG ) Eagle Pharmaceuticals Inc (NASDAQ: EGRX ) Kodiak Sciences Inc (NASDAQ: KOD ) The Medicines Company (NASDAQ: MDCO ) Natera Inc (NASDAQ: NTRA ) Ra Pharmaceuticals Inc (NASDAQ: RARX ) Reata Pharmaceuticals Inc (NASDAQ: RETA ) (announced positive results for a Phase 2 study of its drug to treat Friedreich ataxia) Relmada Therapeutics Inc (NASDAQ: RLMD ) ( announced positive Phase 2 results for drug to treat treatment-resistant depression) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech stocks hitting 52-week lows on Oct. 15) Auris Medical Holding Ltd (NASDAQ: EARS ) BENITEC BIOPHAR/S ADR (NASDAQ: BNTC ) Chimerix Inc (NASDAQ: CMRX ) Cleveland BioLabs, Inc. (NASDAQ: CBLI ) Fulcrum Therapeutics Inc (NASDAQ: FULC ) Heat Biologics Inc (NASDAQ: HTBX ) INmune Bio Inc (NASDAQ: INMB ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Karuna Therapeutics Inc (NASDAQ: KRTX ) Mirum Pharmaceuticals Inc (NASDAQ: MIRM ) Novus Therapeutics Inc (NASDAQ: NVUS ) Orgenesis Inc (NASDAQ: ORGS ) Phio Pharmaceuticals Corp (NASDAQ: PHIO ) Precision BioSciences Inc (NASDAQ: DTIL ) Pulmatrix Inc (NASDAQ: PULM ) Sierra Oncology Inc (NASDAQ: SRRA ) Strongbridge Biopharma plc (NASDAQ: SBBP ) Stocks In Focus Akebia Sues CMS For Restoring Coverage For Kidney-Disease Related Anemia Drug Akebia Therapeutics Inc (NASDAQ: AKBA ) has filed a compliant in federal district court against the Centers of Medicare & Medicaid Service and the U.S.
Chimerix Inc (CMRX) CEO Michelle Berrey on Q3 2018 Results - Earnings Call Transcript 2018-11-08
Chimerix Inc (NASDAQ:CMRX) Q3 2018 Earnings Conference Call November 8, 2018 8:30 AM ET Executives Michelle LaSpaluto - Senior Director-Accounting Michelle Berrey - President and Chief Executive Officer Tim Trost - Chief Financial Officer Garrett Nichols - Chief Medical Offic…